CT83, also known as KK-LC-1, is one such CTA reported to be highly expressed in various cancers, such as gastric cancer, triple-negative breast cancer, lung adenocarcinoma, and cervix cancer [8,9,10,11]. Here, CT83 is linked to triple-negative breast carcinoma.